Osteopathology induced by bisphosphonates and dental implants: clinical observations
Although there are many reports about risk factors for the development of BP-associated osteonecrosis of the jaws, the role of dental implants as a local risk factor is still discussed, especially in patients with oral BP treatment. Until now, a few case reports and surveys display a possible minor risk in patients with oral BP therapy, whereas the avoidance of implant placement is generally accepted in patients with intravenous BP therapy.
Patient and methods
In this study, the cases of 14 patients with osteonecrosis of the jaws in association with BP therapy and dental implant placement were analyzed carefully with a detailed literature review.
Of 14 patients, nine had underlying malignant disease and five patients had osteoporosis. In ten patients, implants were placed either in the posterior mandible or maxilla; the mean interval between implant insertion and disease onset was 20.9 months. Pain (n12) and signs of infection (n10) were the most common symptoms. Histologically, signs of infection were found in nine of 11 analyzed patients with presence of Actinomyces in six patients. Two patients turned out to have infiltration of underlying malignant disease.
Posteriorly placed implants seem to be of higher risk of development of osteonecrosis of the jaws. Not only the implant placement but also the inserted implant itself seems to be a continuous risk factor.
The herein elaborated risk factors help dentists plan dental rehabilitation with implants in this high-risk group of patients and indicate careful and regular dental recall.
KeywordsBisphosphonate-associated osteonecrosis of the jaws (BRONJ) Dental implants Risk factors Posterior jaw Infection
- 2.Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws AAoOaMS (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw—2009 update. Aust Endod J 35:119–130. doi:10.1111/j.1747-4477.2009.00213.x PubMedCrossRefGoogle Scholar
- 8.Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws AAoOaMS (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369–376. doi:10.1016/j.joms.2006.11.003 CrossRefGoogle Scholar
- 10.Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, Surgeons AAoOaM (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67:2–12. doi:10.1016/j.joms.2009.01.009 PubMedGoogle Scholar
- 13.Zahid T, Wang B-Y, Cohen R (2010) Influence of bisphosphonates on alveolar bone loss around osseointegrated implants. J Oral Implantol. doi:10.1563/AAID-JOI-D-09-00114
- 27.Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A (2007) Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 78:1664–1669. doi:10.1902/jop. 2007.060514 PubMedCrossRefGoogle Scholar
- 30.Leonida A, Vescovi P, Baldoni M, Rossi G, Lauritano D (2010) Immediate loading of dental implants in mandible full-arch: pilot study in patients with osteoporosis treated with bassoonists therapy. J Oral Implantol. doi:10.1563/AAID-JOI-D-09-00132.1
- 35.Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA, Jaw ADACoSAEPoB-AOot (2008) Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 139:1674–1677, 1939PubMedGoogle Scholar
- 44.Kaplan I, Anavi K, Anavi Y, Calderon S, Schwartz-Arad D, Teicher S, Hirshberg A (2009) The clinical spectrum of Actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:738–746. doi:10.1016/j.tripleo.2009.06.019 PubMedCrossRefGoogle Scholar